These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14316492)

  • 1. LIPOPROTEIN LIPASE DURING EXTRACORPOREAL CIRCULATION.
    TRIMBLE AS; OSBORN JJ; GERBODE F
    Surgery; 1965 Aug; 58():324-6. PubMed ID: 14316492
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical changes in blood of extracorporeal circulation with an artificial heart-lung].
    MOTOYAMA N
    Nihon Kyobu Geka Gakkai Zasshi; 1961 Oct; 9():961-92. PubMed ID: 14476593
    [No Abstract]   [Full Text] [Related]  

  • 3. [APROPOS OF HEPARIN NEUTRALIZATION AFTER EXTRACORPOREAL CIRCULATION. THE "IN VIVO" PROTAMINE TEST. PRELIMINARY NOTE].
    MONTIES JR; BELLAIS M
    Mars Chir; 1963; 15():468-70. PubMed ID: 14118186
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the heparin activity in the blood in the course of extracorporeal circulation in cardiosurgical operations].
    TOMAI F; TUCCI G
    Ann Ital Chir; 1961 Jan; 38():43-56. PubMed ID: 13777278
    [No Abstract]   [Full Text] [Related]  

  • 5. [STUDIES ON SERUM LIPID CHANGES AND THE APPEARANCE OF FREE FAT DROPS IN EXTRACORPOREAL CIRCULATION].
    KASPAR F
    Thoraxchir Vask Chir (1962); 1965 Feb; 12():481-6. PubMed ID: 14273982
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON THE CONTROL OF ADEQUATE HEPARIN NEUTRALIZATION BY PROTAMINE SULFATE DURING EXTRACORPOREAL CIRCULATION].
    MARGULIS MS; BERZIN UIa
    Vestn Khir Im I I Grek; 1964 Nov; 93():16-22. PubMed ID: 14319691
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of the plasma thrombin time to assess the adequacy of in vivo neutralization of heparin: comparative studies following operations employing extracorporeal circulation.
    PEDEN JC; McFARLAND JA
    Blood; 1959 Nov; 14():1230-6. PubMed ID: 14431320
    [No Abstract]   [Full Text] [Related]  

  • 8. [STUDIES ON BLOOD CHANGES AFTER HYPOTHERMIA AND EXTRACORPOREAL CIRCULATION].
    KASPAR F; GILLERT KE; GRUENERT RD
    Thoraxchir Vask Chir (1962); 1965 Feb; 12():475-81. PubMed ID: 14273981
    [No Abstract]   [Full Text] [Related]  

  • 9. INCIDENCE OF BLEEDING IN CARDIAC SURGERY WITH EXTRACORPOREAL CIRCULATION.
    GILBERT JW; BRECHER G; BRONSON WR
    Ann N Y Acad Sci; 1964 Jul; 115():302-4. PubMed ID: 14192835
    [No Abstract]   [Full Text] [Related]  

  • 10. BLOOD PLATELETS AND EXTRACORPOREAL CIRCULATION.
    SALZMAN EW
    Transfusion; 1963; 3():274-7. PubMed ID: 14048065
    [No Abstract]   [Full Text] [Related]  

  • 11. [Remarks on the use of heparin and neutralizing agents in extracorporeal circulation].
    GANORA HM; LAMBERTINI A; BUGNARD E
    Sem Med; 1962 Oct; 121():1470-4. PubMed ID: 13946406
    [No Abstract]   [Full Text] [Related]  

  • 12. CHANGES OF THE BLOOD COAGULATION MECHANISM DURING EXTRACORPOREAL CIRCULATION.
    PERAESALO O; IKKALA E; TELIVUO L
    J Cardiovasc Surg (Torino); 1963 Aug; 4():642-5. PubMed ID: 14058384
    [No Abstract]   [Full Text] [Related]  

  • 13. [THE MECHANISM OF SO-CALLED "HEPARIN REBOUND" AFTER EXTRACORPOREAL CIRCULATION].
    BROEGLI H
    Thromb Diath Haemorrh; 1965 Jun; 13():401-17. PubMed ID: 14347864
    [No Abstract]   [Full Text] [Related]  

  • 14. [The neutralization of heparin during extracorporeal circulation. Experimentation with a new anti-heparin product].
    BITTARD M; REMIGY E; MARTIN J; BENICHOUX R
    Rev Med Nancy; 1960 Jul; 85():606-15. PubMed ID: 13801050
    [No Abstract]   [Full Text] [Related]  

  • 15. LIPASE ACTIVITY IN BLOOD FROM THE HEPATIC AND PERIPHERAL VASCULAR BEDS FOLLOWING HEPARIN.
    LEQUIRE VS; HAMILTON RL; ADAMS R; MERRILL JM
    Proc Soc Exp Biol Med; 1963 Oct; 114():104-7. PubMed ID: 14076850
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the use of heparin and protamine in cardiovascular surgery with extracorporeal circulation].
    MOTTI VJ
    Rev Bras Cir; 1961 Aug; 42():73-8. PubMed ID: 14476611
    [No Abstract]   [Full Text] [Related]  

  • 17. Relative antiheparin potency of polybrene and protamine in patients undergoing extracorporeal circulation.
    KEATS AS; COOLEY DA; TELFORD J
    J Thorac Cardiovasc Surg; 1959 Sep; 38():362-8. PubMed ID: 14405074
    [No Abstract]   [Full Text] [Related]  

  • 18. The neutralization of heparin by protamine in extracorporeal circulation.
    GERBODE F; HURT R; OSBORN JJ; PERKINS HA
    J Thorac Surg; 1956 Nov; 32(5):612-9. PubMed ID: 13368239
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE USE OF LOW MOLECULAR WEIGHT DEXTRAN AS A PRIMER IN EXTRACORPOREAL CIRCULATION IN EXPERIMENTS ON DEEP HYPOTHERMIA].
    DEORUETA A; CAFFARENA JM; VALLEJO JL; REGODON J
    Rev Clin Esp; 1963 Sep; 90():369-74. PubMed ID: 14091642
    [No Abstract]   [Full Text] [Related]  

  • 20. Behaviour of the antithrombin time after extracorporeal circulation of blood.
    THIES HA
    Thromb Diath Haemorrh; 1960 Jun; 4():400-9. PubMed ID: 13837841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.